| Original language | English |
|---|---|
| Pages (from-to) | 3625-3627 |
| Number of pages | 3 |
| Journal | Annals of Hematology |
| Volume | 102 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2023 |
| Externally published | Yes |
Ibrutinib plus rituximab and lenalidomide for primary intestinal diffuse large B-cell lymphoma relapsed after anti-CD19 CAR-T cell therapy: a case report
- Changyou Li
- , Xiyuan Zhang
- , Danni Zhu
- , Xiaocui Bu
- , Ling Wang
- , Peng Zhao
Research output: Contribution to journal › Letter › peer-review
2
Scopus
citations